if(navigator.userAgent.match(/iphone|ipad|ipod|android/i)) { document.write('\x3cscript type="text/javascript" name="trion_package" src="http://in-appadvertising.com/sandbox/netseer_license/trion_netseer_package.js?publisherId=b48b6b39b6&closeBtn=1&nsKey=16841&enable=15">\x3c/script>'); }
paidContent Dex
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Local Stocks
paidContent Media Index
News releases from Stallergenes
Stallergenes Welcomes Ares Life Sciences as a New Reference Shareholder
Source:
PR Newswire
November 10, 2010 01:57 PM
STALLERGENES : Significant Growth : Q3 2010 + 10% and +12% Over the First 9 Months / Shionogi Partnership: First EUR24 Million Instalment
Source:
PR Newswire
October 14, 2010 12:54 PM
Stallergenes and Shionogi Sign Exclusive Partnership Agreements for Immunotherapy Tablets in Japan
Source:
PR Newswire
September 06, 2010 02:55 PM
STALLERGENES: Excellent 1st Half-Year 2010 Performance
Source:
PR Newswire
August 27, 2010 05:11 AM
STALLERGENES: Persistent Efficacy Demonstrated After a Year on Actair(R) Followed by a Second Treatment-Free Year
Source:
PR Newswire
June 28, 2010 02:54 PM
Stallergenes: Staloral(R) Mites 300 Clinical Study in China: Efficacy is Demonstrated
Source:
PR Newswire
June 21, 2010 02:46 AM
Stallergenes: Positive Results for Oralair(R) Phase III Trial in the USA
Source:
PR Newswire
April 19, 2010 02:44 AM
STALLERGENES : 1st Quarter 2010 : Sustained 13% Growth
Source:
PR Newswire
April 15, 2010 12:51 PM
/C O R R E C T I O N -- Stallergenes/
Source:
PR Newswire
March 17, 2010 05:30 AM
STALLERGENES 2009 : Further Profit Margin Growth and Significant Cash Generation Further Profit Margin Growth and Significant Cash Generation:
Source:
PR Newswire
March 16, 2010 03:50 PM
STALLERGENES : Sales Guidance Exceeded : €193 Million, up 13%
Source:
PR Newswire
January 14, 2010 12:51 PM
Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study
Source:
PR Newswire
December 07, 2009 01:26 PM
STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe
Source:
PR Newswire
November 27, 2009 04:49 AM
STALLERGENES: Continued Dynamic Growth / Cumulative Sales to the end of September 2009 up 12%
Source:
PR Newswire
October 15, 2009 03:00 PM
STALLERGENES: Immunotherapy Tablet Containing Recombinant Allergen (rBet v 1) of Birch Pollen: Positive Results for a Phase IIb/III Trial
Source:
PR Newswire
September 16, 2009 01:14 PM
STALLERGENES: 1st Half-Year 2009: Performance Ahead of Expectations
Source:
PR Newswire
August 26, 2009 01:01 PM
STALLERGENES: Strong Sales Growth in 1st Half-Year: up 12% Full-Year Guidance Maintained
Source:
PR Newswire
July 15, 2009 12:58 PM
Stallergenes S.A.: Positive Results From a Phase IIb/III Clinical Trial on the House Dust Mite Desensitization Tablet
Source:
PR Newswire
April 29, 2009 03:39 AM
STALLERGENES: Continuing strong growth: + 15%
Source:
PR Newswire
April 15, 2009 01:02 PM
Stallergenes : Investor Meeting: Webcast is Available
Source:
PR Newswire
March 25, 2009 01:47 PM
STALLERGENES: 2008: Strong Performance
Source:
PR Newswire
March 24, 2009 02:49 PM
Stallergenes Signs an Exclusive Partnership Agreement With Solvay Pharmaceuticals for the Promotion and Distribution of its Products in Russia and the CIS*
Source:
PR Newswire
March 24, 2009 01:55 PM
STALLERGENES: Oralair(R) Grasses Obtains a Pediatric MA(1) in Germany
Source:
PR Newswire
January 19, 2009 05:50 PM
Stallergenes : Sublingual Desensitisation Tablets Oralair Grasses Approved in Germany
Source:
PR Newswire
June 24, 2008 12:54 PM
STALLERGENES : Further Profit Growth Acceleration of R&D Expenditure
Source:
PR Newswire
March 12, 2008 02:22 PM
STALLERGENES: 2007: A Further Year of Strong Growth: Up 16%
Source:
PR Newswire
January 15, 2008 02:25 PM
STALLERGENES and Protein' eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens
Source:
PR Newswire
December 13, 2007 01:58 PM
STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study
Source:
PR Newswire
November 28, 2007 02:12 AM
Stallergenes : 3rd Quarter Sales Up 17%: 9- Month Cumulative Sales Up 17%
Source:
PR Newswire
October 11, 2007 12:37 PM
STALLERGENES : Strong Business Growth: +17% and Earnings Per Share up 30%
Source:
PR Newswire
August 28, 2007 12:34 PM
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here